Producing leaders in clinical research is a major goal at UT Southwestern. Over the past four years our K30 training program in patient-oriented research (POR) has enrolled over 130 trainees, 65 of whom remain active, and 34 have submitted over 120 grants of which 43% have been funded. Thirty additional full-time faculty mentors have been recruited among whom 17 are basic scientists. In this competitive renewal application we intend to move closer to our goal by fulfilling the following Specific aims: 1) Provide in-depth training and practical experience to foster development of independent (RO-1 funded) -investigators by: a) expanding the curriculum with new interactive courses in genetics and proteomics, clinical pharmacology and drug development, grant writing, translational research, and management; b) creation of dual mentorship of trainees by basic and clinical researchers to enhance scientific rigor and translational research; c) providing practical experience in a mentored POR project; d) beginning the process of writing and submitting a career development award application. In addition, our expanded K30 curriculum will serve as a template for a Masters Degree program in POR, support mentorship as an academic activity and catalyze further procurement of T32, K12, K24 and F32 grants; and 2) Evolve the training program into a self-sustaining (K30-independent) program by the year 2010. To accomplish this aim we will integrate administrative, mentoring and didactic training components into the new Department of Biostatistics and Clinical Science at UT Southwestern, a core clinical research education, training and service facility for Clinical researchers that will become an Academic department in 2004. Our new expanded curriculum is comprehensive, broad-based and takes advantage of the best basic and clinical science resources at UT Southwestern. Continuing support of this grant is critical for UT Southwestern's mission and will ensure that our training program in POR continues to be highly successful and on track to produce leaders in POR.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Clinical Research Curriculum Award (CRCA) (K30)
Project #
9K30RR022269-07
Application #
6846472
Study Section
Special Emphasis Panel (ZHL1-CSR-R (O1))
Program Officer
Wilde, David B
Project Start
1999-06-01
Project End
2010-05-31
Budget Start
2005-09-30
Budget End
2006-05-31
Support Year
7
Fiscal Year
2005
Total Cost
$300,000
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Svatek, Robert S; Karam, Jose A; Roehrborn, Claus G et al. (2008) Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy. Clin Cancer Res 14:3362-6
Karam, Jose A; Svatek, Robert S; Karakiewicz, Pierre I et al. (2008) Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. Clin Cancer Res 14:1418-22
Karam, Jose A; Lotan, Yair; Ashfaq, Raheela et al. (2007) Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. Urology 70:482-6
Karam, Jose A; Shariat, Shahrokh F; Huang, Hong-Ying et al. (2007) Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Clin Cancer Res 13:4400-6
Karam, Jose A; Lotan, Yair; Roehrborn, Claus G et al. (2007) Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 67:614-22
Karam, Jose A; Lotan, Yair; Karakiewicz, Pierre I et al. (2007) Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol 8:128-36
Barber, R C; Chang, L Y; Purdue, G F et al. (2006) Detecting genetic predisposition for complicated clinical outcomes after burn injury. Burns 32:821-7